The Invesco Senior Loan ETF (BKLN) remains a major player in the senior loan market, benefiting from rising yields as the Federal Reserve hikes rates. However, its relatively high expense ratio of 0.65% and less favorable comparison to collateralized loan obligation (CLO) funds make it a cautious choice for investors. Despite favorable macroeconomic conditions supporting senior loans, investors might find better value and income potential in other CLO-focused funds. The analysis reflects the author's independent view and is shared with a private investment community focused on income-generating ETFs and funds.
The BKLN ETF on senior loans is presented here with Pluang's market context for US stocks as of Sep 17, 2026 19:44 WIB: out of 150 priced stocks, 129 rose while 19 fell. Among notable movers, Gold Fields Limited (GFI) gained 4.08% with a Pluang order activity skewed 59% Sell / 41% Buy, contrasting with Caterpillar Inc (CAT) which rose 4.00% and saw 68% Buy orders against 32% Sell, and Lucid Group Inc (LCID) up 3.96% with exclusively Buy orders at 100%. Typical hold times vary from 44 to 95 days, showing diverse investor engagement across these assets.
Ciena reported a 37% revenue increase to $1.67 billion and a 215% rise in adjusted EPS to $2.11 in its fiscal third quarter, driven by strong demand from AI and cloud infrastructure. The company is well positioned to benefit from the AI networking ma...
Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...
Salesforce, a leader in cloud-based CRM software, is driving future growth with its new AIforce platform and ambitious financial goals. The company aims to exceed $63 billion in revenue by 2030, reflecting strong demand for its AI and core software p...
Oscar Health's stock has surged 126% this year, driven by a 47% increase in ACA marketplace enrollment despite overall market declines. The company, now the second-largest insurer on the ACA exchange, has raised its earnings outlook and improved its ...
